Literature DB >> 29800685

Regulation of cancer immune escape: The roles of miRNAs in immune checkpoint proteins.

Qin Yang1, Wenjie Cao2, Zi Wang3, Bin Zhang4, Jing Liu5.   

Abstract

Immune checkpoint proteins (ICPs) are regulators of immune system. The ICP dysregulation silences the host immune response to cancer-specific antigens, contributing to the occurrence and progress of various cancers. MiRNAs are regulatory molecules and function in mRNA silencing and post-transcriptional regulation of gene expression. MiRNAs that modulate the immunity via ICPs have received increasing attention. Many studies have shown that the expressions of ICPs are directly or indirectly repressed by miRNAs in multiple types of cancers. MiRNAs are also subject to regulation by ICPs. In this review, recent studies of the relationship between miRNAs and ICPs (including the PD-1, PD-L1, CTLA-4, ICOS, B7-1, B7-2, B7-H2, B7-H3, CD27, CD70, CD40, and CD40L) in cancer immune escape are comprehensively discussed, which provide critical detailed mechanistic insights into the functions of the miRNA-ICP axes and their effects on immune escape, and will be beneficial for the potential applications of immune checkpoint therapy and miRNA-based guidance for personalized medicine as well as for predicting the prognosis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer immune escape; Immune checkpoint proteins (ICPs); miRNAs

Mesh:

Substances:

Year:  2018        PMID: 29800685     DOI: 10.1016/j.canlet.2018.05.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

Review 1.  microRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics.

Authors:  Marta Gomarasca; Paola Maroni; Giuseppe Banfi; Giovanni Lombardi
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

2.  MiRNA-494 enhances M1 macrophage polarization via Nrdp1 in ICH mice model.

Authors:  Gaohai Shao; Changlong Zhou; Kunlong Ma; Wang Zhao; Qijiang Xiong; Ling Yang; Zhongyan Huang; Zhao Yang
Journal:  J Inflamm (Lond)       Date:  2020-04-25       Impact factor: 4.981

3.  Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer.

Authors:  E Richardsen; S Andersen; S Al-Saad; M Rakaee; Y Nordby; M I Pedersen; N Ness; L M Ingebriktsen; A Fassina; K A Taskén; I G Mills; T Donnem; R M Bremnes; L T Busund
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

4.  miR-149-3p reverses CD8+ T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells.

Authors:  Meng Zhang; Dian Gao; Yanmei Shi; Yifan Wang; Rakesh Joshi; Qiongfang Yu; Daheng Liu; Faizah Alotaibi; Yujuan Zhang; Hongmei Wang; Qing Li; Zhu-Xu Zhang; James Koropatnick; Weiping Min
Journal:  Open Biol       Date:  2019-10-09       Impact factor: 6.411

Review 5.  Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.

Authors:  Le Zhang; Xiaonan Xu; Xiulan Su
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

Review 6.  Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape.

Authors:  Xueqin Zou; Yangjing Zhao; Xiuting Liang; Hui Wang; Yanling Zhu; Qixiang Shao
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

7.  Systematic Evaluation of HLA-G 3'Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome.

Authors:  Vera Rebmann; Esther Schwich; Rafael Tomoya Michita; Lisa Grüntkemeier; Ann-Kathrin Bittner; Hana Rohn; Peter A Horn; Oliver Hoffmann; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

8.  Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer.

Authors:  Qi-Rong Xu; Jian Tang; Hong-Ying Liao; Ben-Tong Yu; Xiang-Yuan He; Yu-Zhen Zheng; Sheng Liu
Journal:  J Transl Med       Date:  2021-06-17       Impact factor: 5.531

Review 9.  miRNA-based biomarkers, therapies, and resistance in Cancer.

Authors:  Boxue He; Zhenyu Zhao; Qidong Cai; Yuqian Zhang; Pengfei Zhang; Shuai Shi; Hui Xie; Xiong Peng; Wei Yin; Yongguang Tao; Xiang Wang
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

10.  MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155.

Authors:  Christian Prinz; David Weber
Journal:  Oncotarget       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.